Clinical Trial Update: Pediatric Epilepsy Trial in Subjects 1-24 Months [Phase 2]

View source ↗

Summary

Phase 2 pediatric epilepsy trial in children aged 1-24 months sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 2 | Status: COMPLETED